The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Stephen Krahling was a published cancer researcher when vaccine maker Merck brought him on board as a virologist in 1999. That’s when he says he found himself embroiled in an all-hands-on-deck ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other most undervalued high quality stocks to buy according to analysts. Is a Market Rally Around ...

executive says Drugmaker Merck , known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the year, a senior company executive said on ...